Characteristic | Placebo | DFA-02 ≤10 mL | DFA-02 >10 mL |
---|---|---|---|
(n = 6) | (n = 16) | (n = 8) | |
Age, years | 56.5 (45.1,60.6) | 70.9 (63.2, 76.3) | 46.9 (41.4, 61.2) |
Gender, % male | 2 (33.3 %) | 6 (37.5 %) | 4 (50 %) |
Race, % white | 5 (83.3 %) | 14 (87.5 %) | 7 (87.5 %) |
Weight, kg | 74.7 (72.3,76.4) | 90.9 (72.3,97.1) | 81.8 (73.3, 97.5) |
Height, cm | 164.3 (157.5, 175.2) | 167.6 (158.7, 175.3) | 171.4 (165.1, 180.4) |
Body mass index (kg/m2) | 28.2 (27.0, 29.9) | 29.1 (27.8, 33.9) | 28.2 (25.7, 30.6) |
Preoperative serum creatinine (mg/dL) | 0.7 (0.7, 0.9) | 0.9 (0.8, 1.3) | 0.9 (0.8, 1.0) |
Duration of surgical procedure (h) | 2.8 (1.4, 4.6) | 2.0 (1.1, 2.3) | 3.0 (2.4, 5.6) |
Length of incision (cm) | 11.3 (8.0, 26.0) | 8.2 (7.8, 10.0) | 8.5 (7.8, 10.5) |
Depth of incision at midpoint (cm) | 2.2 (1.5, 3.0) | 2.5 (1.5, 3.3) | 2.5 (2.0, 3.0) |
Wound area (cm2) | 45.7 (11.1, 79.7) | 22.3 (12.1, 30.0) | 22.8 (18.0, 32.3) |
Study drug volume inserted into wound (mL) | 19.0 (10.0, 20.0) | 10.0 (10.0, 20.0) | 25.0 (20.0, 30.0) |
Overflow study drug collected (mL) | 4.5 (3.0, 7.0) | 5.0 (1.5, 12.5) | 12.0 (6.0, 15.0) |
Volume of study drug retained in wound (mL) | 9.5 (5.0, 17.0) | 5.0 (4.5, 9.8) | 15.0 (12.5, 15.5) |
Volume of study drug per wound area (mL/cm2) | 0.2 (0.2, 0.5) | 0.3 (0.2, 0.4) | 0.6 (0.5, 0.7) |